Total Payments
$27,426
2024 Payments
$4,238
Companies
88
Transactions
1,423
Medicare Patients
18,392
Medicare Billing
$4.7M
Payment Breakdown by Category
Food & Beverage$26,186 (95.5%)
Education$741.36 (2.7%)
Other$498.50 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,186 | 1,395 | 95.5% |
| Education | $741.36 | 23 | 2.7% |
| Long term medical supply or device loan | $498.50 | 5 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,408 | 113 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,104 | 113 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,792 | 114 | $0 (2024) |
| PFIZER INC. | $1,213 | 66 | $0 (2024) |
| Genentech USA, Inc. | $1,196 | 92 | $0 (2023) |
| Amgen Inc. | $1,150 | 51 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,144 | 63 | $0 (2024) |
| Celgene Corporation | $901.30 | 44 | $0 (2024) |
| Eisai Inc. | $898.77 | 41 | $0 (2024) |
| Incyte Corporation | $876.04 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,238 | 184 | AstraZeneca Pharmaceuticals LP ($487.31) |
| 2023 | $5,026 | 191 | Novartis Pharmaceuticals Corporation ($559.52) |
| 2022 | $4,226 | 206 | AstraZeneca Pharmaceuticals LP ($417.96) |
| 2021 | $3,021 | 160 | AstraZeneca Pharmaceuticals LP ($347.83) |
| 2020 | $2,610 | 154 | AstraZeneca Pharmaceuticals LP ($303.55) |
| 2019 | $2,902 | 182 | Genentech USA, Inc. ($354.08) |
| 2018 | $2,567 | 161 | Novartis Pharmaceuticals Corporation ($460.93) |
| 2017 | $2,835 | 185 | Novartis Pharmaceuticals Corporation ($348.39) |
All Payment Transactions
1,423 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/12/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Oncology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Hematology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Oncology | ||||||
| 11/25/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Oncology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Oncology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.02 | General |
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/31/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,864 | 103,326 | $3.1M | $911,298 |
| 2022 | 59 | 4,320 | 107,429 | $3.4M | $997,334 |
| 2021 | 72 | 5,648 | 160,266 | $4.6M | $1.4M |
| 2020 | 74 | 5,560 | 120,579 | $4.0M | $1.3M |
Total Patients
18,392
Total Services
491,600
Medicare Billing
$4.7M
Procedure Codes
243
All Medicare Procedures & Services
243 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 14 | 7,798 | $842,184 | $278,611 | 33.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 97 | 12,480 | $636,480 | $230,730 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 372 | 1,133 | $384,087 | $106,846 | 27.8% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 28 | 10,187 | $234,301 | $59,252 | 25.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 33 | 36 | $133,416 | $39,789 | 29.8% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 12 | 1,800 | $102,600 | $30,146 | 29.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 122 | 435 | $82,215 | $20,349 | 24.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 28 | 174 | $65,772 | $16,992 | 25.8% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 36 | 39 | $26,520 | $15,624 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 529 | 1,841 | $16,569 | $15,456 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 519 | 1,961 | $56,869 | $14,887 | 26.2% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 33 | 33,660 | $134,640 | $13,256 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 191 | $45,649 | $12,008 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 204 | 1,050 | $72,450 | $10,859 | 15.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 71 | $33,654 | $9,705 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $21,744 | $5,878 | 27.0% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 38 | 25,600 | $128,000 | $4,155 | 3.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 54 | 297 | $18,117 | $3,464 | 19.1% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 20 | 21 | $9,807 | $2,810 | 28.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 19 | 167 | $9,352 | $2,523 | 27.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 24 | 114 | $9,576 | $2,476 | 25.9% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 14 | 14 | $7,700 | $2,320 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,605 | $2,244 | 29.5% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 24 | 168 | $7,056 | $1,632 | 23.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 21 | 56 | $8,736 | $1,527 | 17.5% |
About Dr. Hafeez Chatoor, M.D
Dr. Hafeez Chatoor, M.D is a Hematology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174533194.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hafeez Chatoor, M.D has received a total of $27,426 in payments from pharmaceutical and medical device companies, with $4,238 received in 2024. These payments were reported across 1,423 transactions from 88 companies. The most common payment nature is "Food and Beverage" ($26,186).
As a Medicare-enrolled provider, Chatoor has provided services to 18,392 Medicare beneficiaries, totaling 491,600 services with total Medicare billing of $4.7M. Data is available for 4 years (2020–2023), covering 243 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 08/09/2006
- Last Updated 07/09/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1174533194
Products in Payments
- OPDIVO (Biological) $1,173
- Lenvima (Drug) $815.42
- KEYTRUDA (Biological) $813.87
- KISQALI (Drug) $627.84
- JAKAFI (Drug) $549.94
- REBLOZYL (Biological) $491.16
- LYNPARZA (Drug) $482.13
- LIBTAYO (Biological) $472.21
- ELIQUIS (Drug) $466.07
- Enhertu (Drug) $464.16
- ZEJULA (Drug) $422.61
- IMBRUVICA (Drug) $419.39
- Nplate (Biological) $418.99
- CYRAMZA (Drug) $415.00
- ADCETRIS (Biological) $403.67
- CABOMETYX (Drug) $396.21
- CALQUENCE (Drug) $395.31
- IBRANCE (Drug) $394.50
- IMFINZI (Biological) $355.45
- GILOTRIF (Drug) $350.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Tampa
Rami Komrokji, M.d, M.D
Hematology — Payments: $850,782
Hematology $850,782
Dr. Julia Cogburn, M.d, M.D
Hematology — Payments: $133,076
Hematology $133,076
Dr. Robert Weaver, Md, MD
Hematology — Payments: $110,649
Hematology $110,649
Alan List, Md, MD
Hematology — Payments: $94,305
Hematology $94,305
Dr. David Wright, Md, MD
Hematology — Payments: $82,377
Hematology $82,377
Lubomir Sokol, Md, MD
Hematology — Payments: $27,903
Hematology $27,903